Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Sufentanil Sublingual Tablet 30 mcg for the Management of Pain Following Abdominal Surgery: A Randomized, Placebo-Controlled, Phase-3 Study.
Pain Pract. 2017 Sep;17(7):848-858. doi: 10.1111/papr.12531. Epub 2017 Feb 10.
Pain Pract. 2017.
PMID: 27781372
Clinical Trial.
BACKGROUND: Results from a phase-3, prospective, randomized, double-blind, placebo-controlled trial evaluating sufentanil sublingual tablet 30 mcg (SST) for the management of pain after ambulatory abdominal surgery are prese …
BACKGROUND: Results from a phase-3, prospective, randomized, double-blind, placebo-controlled trial evaluating sufentanil sublingu …
An up-to-date overview of sublingual sufentanil for the treatment of moderate to severe pain.
Porela-Tiihonen S, Kokki H, Kokki M.
Porela-Tiihonen S, et al.
Expert Opin Pharmacother. 2020 Aug;21(12):1407-1418. doi: 10.1080/14656566.2020.1766025. Epub 2020 Jun 3.
Expert Opin Pharmacother. 2020.
PMID: 32486875
Review.
Sublingual sufentanil nanotablets have been developed; 15 mcg tablet for a patient-controlled analgesia device and 30-mcg tablet for a single-dose device administered by a healthcare professional. ...EXPERT OPINION: Sufentanil …
Sublingual sufentanil nanotablets have been developed; 15 mcg tablet for a patient-controlled analgesia device a …
Item in Clipboard
Cite
Cite